ArticleRheumatology and therapy2022

Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis.

Sebnem Ataman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.